Merck & Co., Inc.MRKNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank10
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P10
Near historical low
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -100.00% |
| Q3 2025 | 170.26% |
| Q2 2025 | 115.78% |
| Q1 2025 | -53.36% |
| Q4 2024 | -70.46% |
| Q3 2024 | 75.57% |
| Q2 2024 | 117.41% |
| Q1 2024 | 400.00% |
| Q4 2023 | -110.90% |
| Q3 2023 | 148.81% |
| Q2 2023 | 725.00% |
| Q1 2023 | -89.88% |
| Q4 2022 | -26.70% |
| Q3 2022 | 41.07% |
| Q2 2022 | -15.99% |
| Q1 2022 | -1.20% |
| Q4 2021 | 5.46% |
| Q3 2021 | 132.97% |
| Q2 2021 | 136.83% |
| Q1 2021 | -73.64% |
| Q4 2020 | 279.30% |
| Q3 2020 | -75.66% |
| Q2 2020 | 1067.38% |
| Q1 2020 | -107.63% |
| Q4 2019 | 11.94% |
| Q3 2019 | 41.92% |
| Q2 2019 | 210.66% |
| Q1 2019 | -72.17% |
| Q4 2018 | 24.44% |
| Q3 2018 | -23.54% |
| Q2 2018 | 297.02% |
| Q1 2018 | -78.64% |
| Q4 2017 | 304.71% |
| Q3 2017 | -155.13% |
| Q2 2017 | 5616.98% |
| Q1 2017 | -101.72% |
| Q4 2016 | 20.26% |
| Q3 2016 | 106.61% |
| Q2 2016 | -34.01% |
| Q1 2016 | -49.95% |